tiprankstipranks
Advertisement
Advertisement
Repligen to acquire BioLife Solutions for $31 per share, or $1.5B
PremiumThe FlyRepligen to acquire BioLife Solutions for $31 per share, or $1.5B
1d ago
SpaceX initiated, Cloudflare upgraded: Wall Street’s top analyst calls
Premium
The Fly
SpaceX initiated, Cloudflare upgraded: Wall Street’s top analyst calls
16d ago
Repligen upgraded to Buy from Hold at Benchmark
Premium
The Fly
Repligen upgraded to Buy from Hold at Benchmark
16d ago
Repligen Shareholders Approve Directors, Auditor and Pay Plan
PremiumCompany AnnouncementsRepligen Shareholders Approve Directors, Auditor and Pay Plan
2M ago
Repligen resumed with an Outperform at RBC Capital
Premium
The Fly
Repligen resumed with an Outperform at RBC Capital
2M ago
Repligen price target raised to $160 from $145 at Barclays
Premium
The Fly
Repligen price target raised to $160 from $145 at Barclays
3M ago
Repligen reports Q1 adjusted EPS 48c, consensus 38c
PremiumThe FlyRepligen reports Q1 adjusted EPS 48c, consensus 38c
3M ago
RGEN Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
RGEN Upcoming Earnings Report: What to Expect?
3M ago
Repligen price target lowered to $145 from $165 at Canaccord
Premium
The Fly
Repligen price target lowered to $145 from $165 at Canaccord
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100